A Nationwide Cohort Study of Stage I Seminoma Patients Followed on a Surveillance Program

In this nationwide study, we looked at the outcomes of patients with stage I seminoma followed for 5 yr. We found that surveillance is a safe alternative to adjuvant treatment.